Business Daily Media

Men's Weekly

.

The bull market of innovative drug technology is booming, and the leading stock AIM Vaccine has erupted upward

HONG KONG SAR - Media OutReach Newswire - 2 October 2024 - The Hong Kong stock market's pharmaceutical sector has seen a strong rebound recently.
Among them, AIM Vaccine Co., Ltd. (06660.HK) led the rise in the biopharmaceutical sector. Its stock price doubled in the previous five trading days, closing at HK$8.93 on September 30, an increase of 56.12%.

At present, the Hong Kong stock market's pharmaceutical sector has entered a technical bull market, and high-quality growth stocks that were mistakenly underestimated in the early stage are experiencing a return in value. As a leading vaccine company in the industry, according to the company's 2024 Interim Report, AIM Vaccine has 3 heavyweight iterative single-product vaccines are planning to complete the application for marketing in this year, including iterative serum-free rabies vaccine, 13-valent pneumonia conjugate vaccine, and 23-valent pneumonia polysaccharide vaccine. In addition, 7 heavyweight single-product vaccines, including mRNA RSV vaccine (respiratory syncytial virus vaccine) and mRNA shingles/herpes zoster vaccine, have completed the pre-applications for clinical trials, and a series of internationalized business promotions are accelerating implementation.

In the China domestic market, the rabies vaccine market is expected to grow to RMB 22 billion by 2030, mainly due to the potential release of high-end wild vaccine products. It is understood that the iterative serum-free rabies vaccine of AIM Vaccine is completely different from the existing Vero cell rabies vaccine containing serum and human diploid rabies vaccine containing serum, the iterative serum-free rabies vaccine is an iterative product. No serum-free rabies vaccine has been approved for marketing in the global market. The iterative serum-free rabies vaccine of AIM Vaccine has completed the pre-testing for drug registration and is expected to fill the market gap after listing.

The 13-valent pneumonia conjugate vaccine (PCV13) is known as the "king of vaccines". Due to the rapid growth of PCV13, China's pneumococcal vaccine market has grown to RMB 10.75 billion in 2022 and is expected to maintain steady growth at a compound annual growth rate of 22.7%. By 2025, China's pneumococcal vaccine market will reach RMB 24 billion.

The 13-valent pneumonia conjugate vaccine of AIM Vaccine has submitted the pre-application for marketing and is accelerating the work of marketing registration. In addition, the 23-valent pneumonia polysaccharide vaccine has also completed Phase III clinical trial and will soon be unblinded for statistical analysis.

There are also many heavyweight innovative products in the AIM Vaccine R&D pipeline. Among them, the quadrivalent influenza virus vaccine (MDCK Cells) and adsorbed tetanus vaccine have officially submitted clinical trial applications; the iterative 20-valent pneumonia conjugate vaccine has completed clinical pre-application; the tetravalent meningococcal conjugate vaccine and the bivalent HFMD vaccine are accelerating clinical trials; the innovative vaccines mRNA RSV vaccine (respiratory syncytial virus vaccine) and mRNA shingles/herpes zoster vaccine have achieved dual reporting in China and the United States, aiming at the international market.

In the current strong rebound of the pharmaceutical sector, the pipeline covers the world's top ten vaccine varieties, three large single products are coming to market, and several heavyweight innovation large single vaccines have been commercialized in the next 2 to 3 years, which will contribute a steady stream of incremental performance for AIM vaccines and promote the company's high growth expectations.


Hashtag: #AIMVaccine

The issuer is solely responsible for the content of this announcement.

News from Asia

Prudential and Prudence Foundation Provide Free Mental Health Support to Vulnerable Communities

In partnership with Intellect, the programme will be launched in Malaysia and Vietnam to make mental healthcare more accessible for vulnerable or at-risk groups HONG KONG SAR - Media OutReach News...

Trend Micro Named a Leader in IDC MarketScape for CNAPP

HONG KONG SAR - Media OutReach Newswire - 2 July 2025 - Trend Micro Incorporated (TYO: 4704; TSE: 4704), a global cybersecurity leader, today announced it has been named as a Leader in the IDC Ma...

Drug & Medical Device & Aesthetics, 肌顏態 was displayed at the CSD2025, The GeneQueens and 金因敷 launch was grandly held in Changsha

HONG KONG SAR - EQS Newswire - 2 July 2025 - On June 27, 2025, Uni-Bio Science Group Limited (the "Group")grandly held a new medical aesthetics product launch event in Changsha, releasing the high-...

Amazon Singapore Unveils a Week of Prime Day Deals and a Special Public Maze Event for Prime Day 2025

Prime members can access exclusive deals from brands such as Neutrogena, FOREO, Resto, Cricut, Pigeon, PicassoTiles and Coca-Cola from 8 – 14 July. Free Public event: Amazon Prime Day Maze at Sun...

Themed Forum of "Mountain Biodiversity and Our Life" to Kick off "Guizhou Example" Empowering Global Mountain Eco-treatment

GUIYANG, CHINA - Media OutReach Newswire - 2 July 2025 - Recently, Eco Forum Global Guyang 2025 announced at a press briefing that the themed forum "Mountain Biodiversity and Our Life" will be hel...

Asia's First Porsche Design Tower Offers Revolutionary Luxury Living Experience to Bangkok's Vibrant Japanese Community

STUTTGART, GERMANY / TOKYO, JAPAN - Media OutReach Newswire - 24 June 2025 - Porsche Design Tower Bangkok emerges as a defining statement of excellence in luxury automotive-inspired living. As Asi...

Chubb Life Hong Kong Launches Chubb 1792 Club, a Prestigious Global Wealth Centre Designed to Elevate Customer Experience

HONG KONG SAR - Media OutReach Newswire - 16 June 2025 - Chubb Life Hong Kong (Chubb Life HK) today unveiled its first wealth centre, Chubb 1792 Club, marking a pivotal moment in its insurance and...

Cushman & Wakefield Greater China Wins Three Best Five-Star Awards at 2025 Asia Pacific Property Awards

HONG KONG SAR - Media OutReach Newswire - 19 June 2025 - Cushman & Wakefield, a leading global real estate services firm, has again been recognized at the Asia Pacific Property Awards, scoring...

Cushman & Wakefield and Corenet Global Release New Survey Results On "What Occupiers Want"

Cost remains king, but talent, flexibility, and service are reshaping real estate strategy globally HONG KONG SAR - Media OutReach Newswire - 2 July 2025 - Cushman & Wakefield (NYSE: CWK), in ...

Hong Kong banks showed moderate balance sheet growth amid global uncertainty in 2024, KPMG report finds

Disciplined cost management, risk vigilance, and digital innovation underpin sector resilience HONG KONG SAR - Media OutReach Newswire - 2 July 2025 – Hong Kong's banking sector demonstrated stead...

The Next Generation of Maritime Sustainable Solutions

As organizations globally seek innovative ways to improve sustainability and their impact on Earth, the American Waterways Operators (AWO), a lead...

Demand for Home Batteries surges as Federal Rebate Kicks In

A leading provider of energy solutions VoltX Energy has seen a 400% increase in demand for home batteries in the past three weeks as people put d...

Why Sport Remains the Safest Bet in an Uncertain World

When Rome was in crisis, its leaders did not retreat to the Senate. They went to the circus. To the chariot races. To the gladiators. Sport was no...

THE FINE LINE WITHIN HILARIOUS SIGNAGE DESIGN FAILS

It seems like design failures still occur in today’s modern branding era, despite rigorous rounds of approvals behind the scenes. One signage show...

Deputy Announces Exclusive Global Partnership with Predelo to Bring AI to Shift-Based Businesses

Deputy, the global people platform for shift-based businesses, has announced an exclusive partnership with Predelo, an AI Decision Agent-as-a-Serv...

Leftover Budget? The Last-Minute EOFY Tip to Drive Business Success in FY25/26

The countdown is on. With just days left until EOFY, now’s the time to make your remaining 2024–2025 budget work harder and smarter. After workin...

Sell by LayBy